NYCEDC's blog

NYCEDC Announces Partnership to Create Harlem Biospace


NYCEDC today announced a partnership that will lead to the creation of Harlem Biospace, a new life sciences incubator which will provide affordable wet lab and microbench facilities, specialized laboratory equipment, mentorship, and business support to early-stage life sciences companies. Designed to help create a thriving biotech community for turning revolutionary ideas into products that will solve important health problems, the initiative will provide up to 20 startup biotech companies with the tools and resources they need to grow in New York City.

NYCEDC is launching this initiative in partnership with Sam Sia, PhD, an entrepreneur and faculty member at Columbia University’s Department of Biomedical Engineering and Founder of Harlem Biospace. As a life sciences researcher and entrepreneur, Dr. Sia brings extensive leadership and industry experience to this project. He previously founded Claros Diagnostics, a venture capital-backed company which was acquired by Opko Health in 2011.

“Harlem Biospace will fill a critical void that currently exists within New York City’s biotech sector, providing small and early stage companies with the tools they need to grow and solve important health issues. With increased access to equipment and mentorship, this incubator will allow these early stage life sciences companies to prosper and help make New York City a leading center for biotech innovation.” - NYCEDC Executive Director Kyle Kimball

Harlem Biospace, which will be located at 423 W. 127th Street in Harlem, will further the City’s efforts to encourage entrepreneurship and innovation across a variety of sectors. The 2,300-square-foot space will provide 20 companies with ergonomic work desks, wet lab benches, and access to shared laboratory resources including a cell-culture hood, incubators, a centrifuge, an autoclave, a chemical fume hood, microscopy, freezers and all utilities, WiFi, and printing. NYCEDC provided approximately $626,000 in financial support to offset capital improvements, equipment, operations and programming. The space is expected to open this fall.

Growing New York City’s commercial life sciences industry is a central goal in NYCEDC’s efforts to diversify the economy, spur entrepreneurship and promote high-growth industries in which the City has competitive advantages. New York City is home to an increasingly robust life sciences sector, which includes world-class academic medical centers, research foundations, pharmaceutical companies, venture capital firms and clinical care centers. Harlem Biospace will foster unique R&D and new venture collaborations across New York City’s academic and commercial life sciences stakeholders.

Entrepreneurs interested in obtaining space at the Harlem Biospace incubator should visit



Featured Blog Post